Researchers Advance CAR T-Cell Safety with Remote Control and Risk Prediction Studies
New research addresses CAR T-cell therapy safety through a venetoclax-controlled on-off switch and a prospective study identifying neurotoxicity risk markers in pediatric patients with acute lymphoblastic leukemia.